Editorial Comment from Dr Matsumoto to Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guérin treatment

MeSH terms

• Adjuvants, Immunologic / therapeutic use
• Administration, Intravesical
• BCG Vaccine / therapeutic use
• Humans
• Japan
• Mycobacterium bovis*
• Neoplasm Invasiveness
• Neoplasm Recurrence, Local / drug therapy
• Urinary Bladder Neoplasms* / drug therapy